Swiss agrichemicals and seeds group Syngenta generated double-digit growth in the second quarter ahead of the Chinese-owned company’s planned flotation by year’s end.
Sales increased 24 per cent to $9.2 billion (€9.2 billion) while earnings before interest, tax, depreciation and amortisation (Ebitda) rose 39 per cent to $1.7 billion, the company said, citing launches of new products and services, increased productivity and prices that offset higher costs.
All business units achieved double-digit sales growth in the quarter and the first half of 2022, it said. Its Ebitda margin improved by 1.1 percentage points from a year earlier to 19.5 per cent in the first half of 2022.
Syngenta Group had increased first-quarter sales by 26 per cent to $8.9 billion as farmers bought seeds and sprays early to avoid possible shortages, the company said in April. Core profit rose 25 per cent to $1.9 billion in the first three months.
Ireland faces EU bill of up to €26bn if it misses climate targets
Microsoft emphasises commitment to Ireland, which can ‘count on us’
Moving to New Zealand may not be enough to avoid Donald Trump
I’m in my 70s and have €500,000 in savings. If I need to go into a nursing home, what happens if I run out of money?
Syngenta, which competes with US company Corteva and Germany’s BASF and Bayer, was bought in 2017 for $43 billion by ChemChina, which was folded into Sinochem Holdings Corp last year. The parent company plans to keep a majority stake after the $10 billion flotation, which is expected to value Syngenta at around $50 billion. — Reuters
